Wobblebase is a cutting-edge bioresearch laboratory that specializes in genetic engineering and biotechnology advancements, focusing on molecular diagnostic research. The company offers a comprehensive range of products and services, including nucleic acid extraction reagents and diagnostic assays for various infectious diseases, oncology, and inherited conditions. Their product catalog encompasses solutions for bloodborne infections, bacterial infections, sexually transmitted infections, respiratory infections, and thrombotic mutations, among others. This diverse offering positions Wobblebase as a key player in the molecular diagnostics field, dedicated to improving healthcare outcomes through innovative biotechnology solutions.

In addition to their product offerings, Wobblebase emphasizes research and development, providing services such as gene expression studies, synthetic RNA expression, and custom molecular biology studies. Their commitment to advancing diagnostic healthcare is evident in their focus on discovering and delivering effective solutions that address the complexities of DNA and RNA in relation to health. By executing research projects and offering hands-on training in basic molecular biology, Wobblebase aims to foster a deeper understanding of molecular diagnostics and contribute to the overall improvement of health on a global scale.

India

Provides extraction and diagnostic kits.COVID-19: WobbleBase Bioresearch Pvt Ltd is introducing CovidXtract, a completely ‘Made in India’ Viral RNA extraction kit to facilitate scalling up the testing of COVID-19 in india. This kit is designed to facilitate Mass screening by minimum TAT and without need of any special infrastructure for extraction.

Wobblebase

Company Details